Yokohama City University

Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials.

2023.11.27

For inquiries regarding this article

Nobuyuki Horita
Director
Chemotherapy Center, Yokohama City University Hospital
Yokohama, Japan